Johnson & Johnson Gets Punitive Damages in Risperdal Case Reduced to $6.8 Million [The Motley Fool]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: The Motley Fool
Healthcare giant Johnson & Johnson ( NYSE:JNJ The original fine was awarded by a jury to a plaintiff who experienced unwanted side effects from the company's Risperdal medication, which is used to treat people with schizophrenia, bipolar disorder, and it also helps people with autism. The plaintiff in the case, Nicholas Murray, began taking the medication as a child to treat behaviors related to autism, but the drug caused the young man to grow breasts -- a condition called gynecomastia. The punitive damages were in addition to a $80,000 compensatory award the plaintiff would receive. Johnson & Johnson challenged the ruling, and today it learned of the reduction to the punitive fees. Image source: Getty Images. Just one of many problems for J&J Friday's ruling offers some much-needed positivity for Johnson & Johnson, as it has been under pressure for the past few years from product liability litigation. Some consumers alleged the company's baby powder products led them to develop ovar
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson's latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years [Fortune]Fortune
- Johnson & Johnson Proposes $6.5 Billion in New Talc Settlement Offer [The New York Times]The New York Times
- Johnson & Johnson offers to pay $6.5 billion to settle talc ovarian cancer lawsuits [CBS News]CBS News
- The New York Jets Go on the Offense at the Lupus Research Alliance 2024 New Jersey "Walk with Us to Cure Lupus" [Yahoo! Finance]Yahoo! Finance
- J&J hopes for deal with third talc settlement [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 4/16/24 - Beat
JNJ
Sec Filings
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/29/24 - Form 4
- JNJ's page on the SEC website